Cargando…
Platelet miRNA Biosignature Discriminates between Dementia with Lewy Bodies and Alzheimer’s Disease
Dementia with Lewy bodies (DLB) is one of the most common causes of degenerative dementia, after Alzheimer’s disease (AD), and presents pathological and clinical overlap with both AD and Parkinson’s disease (PD). Consequently, only one in three DLB cases is diagnosed correctly. Platelets, previously...
Autores principales: | Gámez-Valero, Ana, Campdelacreu, Jaume, Vilas, Dolores, Ispierto, Lourdes, Gascón-Bayarri, Jordi, Reñé, Ramón, Álvarez, Ramiro, Armengol, Maria P., Borràs, Francesc E., Beyer, Katrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466211/ https://www.ncbi.nlm.nih.gov/pubmed/34572457 http://dx.doi.org/10.3390/biomedicines9091272 |
Ejemplares similares
-
Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer’s disease and dementia with Lewy bodies
por: Gámez-Valero, Ana, et al.
Publicado: (2019) -
Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson’s Disease
por: Marsal-García, Laura, et al.
Publicado: (2021) -
Glucocerebrosidase mRNA is Diminished in Brain of Lewy Body Diseases and Changes with Disease Progression in Blood
por: Perez-Roca, Laia, et al.
Publicado: (2018) -
Comprehensive proteomic profiling of plasma-derived Extracellular Vesicles from dementia with Lewy Bodies patients
por: Gámez-Valero, Ana, et al.
Publicado: (2019) -
Severe Hyperammonemia in Late-Onset Ornithine Transcarbamylase Deficiency Triggered by Steroid Administration
por: Gascon-Bayarri, Jordi, et al.
Publicado: (2015)